1. Samir Mitragotri was born on 28 May 1971 and is an Indian American professor at Harvard University, an inventor, an entrepreneur, and a researcher in the fields of drug delivery and biomaterials.

1. Samir Mitragotri was born on 28 May 1971 and is an Indian American professor at Harvard University, an inventor, an entrepreneur, and a researcher in the fields of drug delivery and biomaterials.
Samir Mitragotri is currently the Hiller Professor of Bioengineering and Hansjorg Wyss Professor of Biologically Inspired Engineering at Harvard John A Paulson School of Engineering and Applied Sciences and the Wyss Institute for Biologically Inspired Engineering.
Samir Mitragotri invented techniques to deliver drugs transdermally using low-frequency ultrasound, pulsed microjet injector, high throughput skin experimentation, skin penetrating peptides and ionic liquids.
Samir Mitragotri invented intestinal patches and ionic liquids for oral delivery of proteins.
Samir Mitragotri pioneered nanoparticle-enabled cell therapies which use drug-loaded nanoparticles that hitch a ride on red blood cells, monocytes and other circulatory cells for tissue-specific delivery.
Samir Mitragotri's technologies are used to develop next generation therapies against diabetes, cancer, psoriasis, hemorrhage, trauma and infections.
Samir Mitragotri's publications are cited over 74000 times with an h-index of 135.
Samir Mitragotri is a member of the National Academy of Medicine and the National Academy of Inventors.
Samir Mitragotri is a member of the US National Academy of Engineering since 2015 for the development, clinical translation, and commercialization of transdermal drug delivery systems.
Samir Mitragotri is a co-founder of several companies that are developing products based on his inventions.
Samir Mitragotri received his PhD in chemical engineering at MIT and BS in chemical engineering from the Institute of Chemical Technology.
Samir Mitragotri serves on the editorial boards of several journals and has served as the founding editor-in-chief of Bioengineering and Translational Medicine.